Hakan Genç1, Melahat Atasever2, Burcu Duyur Çakit1, Murat Seval3, Acar Koç3. 1. Department of Physical Medicine and Rehabilitation, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Turkey. 2. Department of Gynecology and Obstetric, Medical Faculty of Giresun University, Giresun, Turkey. 3. Department of Gynecology and Obstetric, Medical Faculty of Ankara University, Ankara, Turkey.
Abstract
OBJECTIVES: This study aims to investigate the frequency and most common symptoms of fibromyalgia syndrome (FS) among pregnant females and determine the impacts of FS on physical functioning and psychological status. PATIENTS AND METHODS: A total of 360 pregnant females (mean age 26.5 years, range 19 to 42 years) were included. The subjects were divided into two groups in terms of having (FS group; n=136; mean age 27 years; range 19 to 41 years) or not having FS (control group; n=224; mean age 26.5 years; range 20 to 42 years). The impact of FS on physical functions was evaluated using Fibromyalgia Impact Questionnaire. Psychological statuses of the subjects were evaluated using State-Trait Anxiety Inventory, Wijma Delivery Expectancy/Experience Questionnaire, and Beck Depression Inventory. RESULTS: Low back pain was the most common complaint while fatigue was the most common symptom in FS group. FS group had higher levels of pain and physical disability (p<0.001) and also higher values of anxiety, fear of childbirth, and depression (p<0.001, for all values) compared to control group. Symptom severity and physical function scores were significantly correlated with increased levels of pain, depression, anxiety, and fear of childbirth (p<0.001, for all values). CONCLUSION: Fibromyalgia syndrome is common among pregnant females. The existence of FS in pregnancy is a severe factor contributing to maternal stress, anxiety, and depression. Therapeutic measures for fibromyalgia syndrome should be well-established to support healthy pregnancy and good child health outcome.
OBJECTIVES: This study aims to investigate the frequency and most common symptoms of fibromyalgia syndrome (FS) among pregnant females and determine the impacts of FS on physical functioning and psychological status. PATIENTS AND METHODS: A total of 360 pregnant females (mean age 26.5 years, range 19 to 42 years) were included. The subjects were divided into two groups in terms of having (FS group; n=136; mean age 27 years; range 19 to 41 years) or not having FS (control group; n=224; mean age 26.5 years; range 20 to 42 years). The impact of FS on physical functions was evaluated using Fibromyalgia Impact Questionnaire. Psychological statuses of the subjects were evaluated using State-Trait Anxiety Inventory, Wijma Delivery Expectancy/Experience Questionnaire, and Beck Depression Inventory. RESULTS: Low back pain was the most common complaint while fatigue was the most common symptom in FS group. FS group had higher levels of pain and physical disability (p<0.001) and also higher values of anxiety, fear of childbirth, and depression (p<0.001, for all values) compared to control group. Symptom severity and physical function scores were significantly correlated with increased levels of pain, depression, anxiety, and fear of childbirth (p<0.001, for all values). CONCLUSION: Fibromyalgia syndrome is common among pregnant females. The existence of FS in pregnancy is a severe factor contributing to maternal stress, anxiety, and depression. Therapeutic measures for fibromyalgia syndrome should be well-established to support healthy pregnancy and good child health outcome.
Entities:
Keywords:
Fibromyalgia syndrome; physical function; pregnancy; psychological status
Authors: Michael E Geisser; Cathy Strader Donnell; Frank Petzke; Richard H Gracely; Daniel J Clauw; David A Williams Journal: Psychosomatics Date: 2008 May-Jun Impact factor: 2.386
Authors: Agnes M Schitter; Marko Nedeljkovic; Heiner Baur; Johannes Fleckenstein; Luigi Raio Journal: Evid Based Complement Alternat Med Date: 2015-03-01 Impact factor: 2.629
Authors: Sybille Kramer; Lana Deuschle; Niko Kohls; Martin Offenbächer; Andreas Winkelmann Journal: Arch Rheumatol Date: 2020-04-17 Impact factor: 1.472